R. A. Mulnard, C.W. Cotman, C. Kawas, R. J. Elble, P. F. Reyes, D. Shoupe, C.A. McCleary, R. A. Klein, A. M. Hake and M. R. Farlow, “Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer’s Disease, A Randomised Control Trial, Alzheimer’s Disease Corporative Study,” Journal of the American Medical Association, Vol. 283, No. 8, 2000, pp. 1007-1015. doi:10.1001/jama.283.8.1007

has been cited by the following article:

• TITLE: The Functions of the Amyloid Precursor Protein Gene and Its Derivative Peptides: III Pharmacological Studies

  AUTHORS: Peter K. Panegyres, Emily R. Atkins

  KEYWORDS: Amyloid Precursor Protein, APP, Genes, Dementia, Alzheimer’s Disease

  JOURNAL NAME: Neuroscience and Medicine, Vol.2 No.4, December 2, 2011

  ABSTRACT: Pharmacological studies reveal APP and Aβ have interactions with glutamate and calcium, cytokines, copper/zinc chelators, secretases and presenilins, nicotinic receptors, acetycholinesterase, neurotrophins, non-steroidal anti-inflame-matory drugs, monoclonal antibodies to Aβ, protease inhibitors, oestrogen, homocysteine, immediate early genes such as c-fos or c-jun and cholesterol. These functional and pharmacological observations highlight the need for greater understanding of APP and Aβ in brain function and have implications for clinical trials.